P-31 NMR-SPECTROSCOPY IN CHRONIC ADRIAMYCIN CARDIOTOXICITY

被引:10
作者
BITTNER, V
REEVES, RC
DIGERNESS, SB
CAULFIELD, JB
POHOST, GM
机构
[1] UNIV ALABAMA,DIV CARDIAC SURG,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,DEPT PATHOL,BIRMINGHAM,AL 35294
关键词
D O I
10.1002/mrm.1910170112
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Abnormal cardiac energy metabolism has been postulated as a mechanism for adriamycin induced cardiotoxicity. This study was designed to determine high energy phosphate stores at rest and with hemodynamic stress in perfused rat hearts after animals had been chronically exposed to adriamycin (2 mg/kg weekly for 14 weeks). Morphologic and hemodynamic changes were mild in this model. Phosphorus‐31 NMR determined intracellular pH and levels of inorganic phosphate (Pi) and ATP were comparable in treated and control hearts. Phosphocreatine (PCr) levels were markedly decreased in treated hearts (0.89 ± 0.07 units/g versus 1.7 ± 0.13 units/g, p < 0.001). The PCr/Pi ratio decreased in both groups during hemodynamic stress. It recovered earlier in controls and there was a marked overshoot after cessation of rapid pacing in this group which was not present in adriamycin treated hearts. These results suggest that metabolic regulation in response to hemodynamic stress is impaired after chronic adriamycin exposure. PCr depletion and delayed metabolic recovery after hemodynamic stress appear to be potentially useful markers for the effect of adriamycin on the heart. © 1991 Academic Press, Inc. Copyright © 1991 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:69 / 81
页数:13
相关论文
共 34 条
  • [1] SERIAL ASSESSMENT OF DOXORUBICIN CARDIOTOXICITY WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY
    ALEXANDER, J
    DAINIAK, N
    BERGER, HJ
    GOLDMAN, L
    JOHNSTONE, D
    REDUTO, L
    DUFFY, T
    SCHWARTZ, P
    GOTTSCHALK, A
    ZARET, BL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) : 278 - 283
  • [2] BALCERZAK SP, 1978, CANCER TREAT REP, V62, P893
  • [3] BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865
  • [4] BREED JGS, 1979, CANCER TREAT REP, V63, P869
  • [5] DOSE-EFFECT AND STRUCTURE-FUNCTION-RELATIONSHIPS IN DOXORUBICIN CARDIOMYOPATHY
    BRISTOW, MR
    MASON, JW
    BILLINGHAM, ME
    DANIELS, JR
    [J]. AMERICAN HEART JOURNAL, 1981, 102 (04) : 709 - 718
  • [6] Caulfield J B, 1985, Adv Myocardiol, V5, P257
  • [7] DEWILDT DJ, 1985, J PHARMACOL EXP THER, V235, P234
  • [8] ACUTE EFFECTS OF DOXORUBICIN (ADRIAMYCIN) ON LEFT-VENTRICULAR FUNCTION IN DOGS
    DITCHEY, RV
    LEWINTER, MM
    HIGGINS, CB
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1984, 6 (03) : 341 - 350
  • [9] DOERING HJ, 1987, ISOLATED PERFUSED WA
  • [10] EWY GA, 1978, CANCER TREAT REP, V62, P915